[go: up one dir, main page]

WO2003006034A3 - Formulation medicinale - Google Patents

Formulation medicinale Download PDF

Info

Publication number
WO2003006034A3
WO2003006034A3 PCT/IB2002/002701 IB0202701W WO03006034A3 WO 2003006034 A3 WO2003006034 A3 WO 2003006034A3 IB 0202701 W IB0202701 W IB 0202701W WO 03006034 A3 WO03006034 A3 WO 03006034A3
Authority
WO
WIPO (PCT)
Prior art keywords
aloa
mixture
herbal formulation
herbs
barbedensis
Prior art date
Application number
PCT/IB2002/002701
Other languages
English (en)
Other versions
WO2003006034A2 (fr
Inventor
Ranjitsinh Solanki
Original Assignee
Sahajanand Biotech Private Ltd
Ranjitsinh Solanki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/257,092 priority Critical patent/US6649185B2/en
Application filed by Sahajanand Biotech Private Ltd, Ranjitsinh Solanki filed Critical Sahajanand Biotech Private Ltd
Priority to AU2002345278A priority patent/AU2002345278A1/en
Publication of WO2003006034A2 publication Critical patent/WO2003006034A2/fr
Publication of WO2003006034A3 publication Critical patent/WO2003006034A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une préparation pharmaceutique ou médicinale comprenant un mélange des sept plantes suivantes: Tinospora cordifolia, Aloa vera (Aloa barbedensis), Curcuma longa, Withania somnifera, Achyranthus aspera, Ocimum sanctum et Picorrhiza kurroa, ou un mélange des principes actifs ayant été extraits à partir de ces plantes, ou chimiquement synthétisés. Cette formulation médicinale est efficace pour le traitement du cancer, et en particulier, de malignités hématologiques.
PCT/IB2002/002701 2001-07-11 2002-07-11 Formulation medicinale WO2003006034A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/257,092 US6649185B2 (en) 2001-07-11 2002-07-10 Herbal formulation
AU2002345278A AU2002345278A1 (en) 2001-07-11 2002-07-11 Herbal formulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0116949.9A GB0116949D0 (en) 2001-07-11 2001-07-11 Herbal formulation
GB0116949.9 2001-07-11

Publications (2)

Publication Number Publication Date
WO2003006034A2 WO2003006034A2 (fr) 2003-01-23
WO2003006034A3 true WO2003006034A3 (fr) 2004-05-27

Family

ID=9918323

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/002701 WO2003006034A2 (fr) 2001-07-11 2002-07-11 Formulation medicinale

Country Status (4)

Country Link
US (1) US6649185B2 (fr)
AU (1) AU2002345278A1 (fr)
GB (2) GB0116949D0 (fr)
WO (1) WO2003006034A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4153485B2 (ja) * 2002-07-15 2008-09-24 ユニリーバー・ナームローゼ・ベンノートシヤープ 毛髪および／または頭皮トリートメント用組成物
GB0317020D0 (en) * 2003-07-21 2003-08-27 Sahajanand Biotech Private Ltd Herbo-mineral formulation for refractory leukemias and lymphomas
WO2005077392A1 (fr) * 2004-01-19 2005-08-25 Ranbaxy Laboratories Limited Formulation a base de plantes medicinales comprenant des extraits de withania, tinospora and picrorhiza servant de tonique en pediatrie
AU2005229008B2 (en) * 2004-03-23 2011-03-24 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
WO2006067796A1 (fr) * 2004-12-24 2006-06-29 Council Of Scientific And Industrial Research Formulation galenique servant de stimulateur de la memoire dans la maladie d’alzheimer
WO2006134609A2 (fr) * 2005-06-16 2006-12-21 Mmi Corporation Nouvel agent anticancereux, procedes de preparation et compositions pharmaceutiques correspondantes
EP1926492B1 (fr) * 2005-09-12 2010-10-13 BENDALE. N, Yogesh Nouveau platine biologique, procede de preparation et procede d'administration pour un traitement antitumoral
WO2008120220A1 (fr) 2007-04-03 2008-10-09 Ganga Raju Gokaraju Compositions de compléments alimentaires anti-inflammatoires et antioxydants synergiques
WO2009066303A2 (fr) * 2007-11-22 2009-05-28 Ganga Raju Gokaraju Nouvelle composition phytochimique synergique pour le traitement de l'obésité
US10391138B2 (en) * 2017-07-11 2019-08-27 Muniyal Ayurvedic Research Centre Multidimensional approach for Cancer treatment
US20240315953A1 (en) * 2023-03-24 2024-09-26 Ameka COLEMAN Hair care composition and methods of preparing the same and preparing plant extracts

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913727A (ja) * 1982-07-13 1984-01-24 Lion Corp 抗腫瘍性物質の製造方法
WO1991008750A1 (fr) * 1989-12-19 1991-06-27 Krueger Christian Utilisation de parties de la plante naturelle tinospora
CN1174683A (zh) * 1997-09-17 1998-03-04 王素艳 芦荟活性饮料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693327A (en) * 1995-07-12 1997-12-02 Shah; Eladevi Herbal compositions
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913727A (ja) * 1982-07-13 1984-01-24 Lion Corp 抗腫瘍性物質の製造方法
WO1991008750A1 (fr) * 1989-12-19 1991-06-27 Krueger Christian Utilisation de parties de la plante naturelle tinospora
CN1174683A (zh) * 1997-09-17 1998-03-04 王素艳 芦荟活性饮料

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198409, Derwent World Patents Index; Class B04, AN 1984-053808, XP002221325 *
DATABASE WPI Section Ch Week 200211, Derwent World Patents Index; Class B04, AN 2002-075750, XP002221324 *
DEVI P UMA: "Radioprotective, anticarcinogenic and antioxidant properties of the Indian holy basil, Ocimum sanctum (Tulasi).", INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, vol. 39, no. 3, March 2001 (2001-03-01), pages 185 - 190, XP009002019, ISSN: 0019-5189 *
EGGER STEFAN F ET AL: "Studies on optimal dose and administration schedule of a hematopoietic stimulatory beta-(1,4)-linked mannan.", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, vol. 18, no. 2, 1996, pages 113 - 126, XP002221318, ISSN: 0192-0561 *
JAGETIA G C ET AL: "Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa cells", CANCER LETTERS, NEW YORK, NY, US, vol. 127, 1998, pages 71 - 82, XP002196031, ISSN: 0304-3835 *
KARTHIKEYAN K ET AL: "Anticancer activity of Ocimum sanctum.", PHARMACEUTICAL BIOLOGY, vol. 37, no. 4, October 1999 (1999-10-01), pages 285 - 290, XP009002018, ISSN: 1388-0209 *
LEE KEYONG HO ET AL: "Induction of apoptosis in human leukaemic cell lines K562, HL60 and U937 by diethylhexylphthalate isolated from Aloe vera Linne.", JOURNAL OF PHARMACY AND PHARMACOLOGY, vol. 52, no. 8, August 2000 (2000-08-01), pages 1037 - 1041, XP009001187, ISSN: 0022-3573 *
MANJREKAR P N ET AL: "Comparative studies of the immunomodulatory activity of Tinospora cordifolia and Tinospora sinensis.", FITOTERAPIA, vol. 71, no. 3, June 2000 (2000-06-01), pages 254 - 257, XP002221321, ISSN: 0367-326X *
MENON L G ET AL: "Effect of rasayanas in the inhibition of lung metastasis induced by B16F-10 melanoma cells.", JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH: CR. ITALY DEC 1997, vol. 16, no. 4, December 1997 (1997-12-01), pages 365 - 368, XP009000344, ISSN: 0392-9078 *
MORIGUCHI I ET AL: "STRUCTURE ACTIVITY STUDIES OF WITHAFERIN ANALOGS USING THE ADAPTIVE LEAST-SQUARES METHOD", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 16, no. 1, 1981, pages 19 - 23, XP009001205, ISSN: 0223-5234 *
RAMSEWAK R S ET AL: "Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa.", PHYTOMEDICINE: INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY. GERMANY JUL 2000, vol. 7, no. 4, July 2000 (2000-07-01), pages 303 - 308, XP009002017, ISSN: 0944-7113 *
SHARADA A CHANDRASHEKAR ET AL: "Antitumor and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma in vivo.", ACTA ONCOLOGICA (STOCKHOLM), vol. 35, no. 1, 1996, pages 95 - 100, XP009000328, ISSN: 0284-186X *
SHERLEKAR R R ET AL: "In vitro effect of Tinospora cordifolia on leukemic cell proliferation.", INDIAN JOURNAL OF PHARMACOLOGY, vol. 33, no. 2, April 2001 (2001-04-01), XXXIII Annual Conference of the Indian Pharmacological Society;Ganghinagar, India; December 28-30, 2000, pages 130, XP009001178, ISSN: 0253-7613 *
SINGH N ET AL: "PREVENTION OF URETHANE-INDUCED LUNG ADENOMAS BY WITHANIA-SOMNIFERA IN ALBINO MICE", INTERNATIONAL JOURNAL OF CRUDE DRUG RESEARCH, vol. 24, no. 2, 1986, pages 90 - 100, XP009001212, ISSN: 0167-7314 *

Also Published As

Publication number Publication date
US6649185B2 (en) 2003-11-18
GB0116949D0 (en) 2001-09-05
US20030152585A1 (en) 2003-08-14
GB2378384B (en) 2003-09-17
GB0216104D0 (en) 2002-08-21
WO2003006034A2 (fr) 2003-01-23
GB2378384A (en) 2003-02-12
AU2002345278A1 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
WO2003006034A3 (fr) Formulation medicinale
JP6966998B2 (ja) 口腔、咽喉及び気道の障害の治療のための配合物
CL2004001170A1 (es) Combinacion farmaceutica inhalable que contiene (a) formoterol, o una sal, o un solvato de el o de la sal y (b) furoato de mometasona; estuche farmaceutico que la comprende; y su uso en la terapia de una enfermedad inflamatoria u obstructiva de las v
BR0114760A (pt) Composição herbácea medicinal para tratar doenças do fìgado e hiv
KR20090039829A (ko) 개선된 항염증성 약초 조성물 및 이의 사용 방법
Oladimeji et al. Appraisal of bioenhancers in improving oral bioavailability: applications to herbal medicinal products
Jahan et al. Future prospects of cough treatment, herbal medicines v/s modern drugs
US20110159124A1 (en) Compositions and methods useful for treatment of respiratory illness
Prabha et al. Nano-platform strategies of herbal components for the management of rheumatoid arthritis: A review on the battle for next-generation formulations
Qadir et al. Protective role of ginseng against gentamicin induced changes in kidney of albino mice
WO2003006036A3 (fr) Preparation a base de plantes
KR20160113631A (ko) 말초성 염증 및 통증을 감소시키는데 유용한 울금 및 에키네시아 안구스티폴리아의 추출물을 함유하는 조성물
WO2006040596A3 (fr) Compositions pour administration intranasale
Rana et al. Role of bioactive compounds, novel drug delivery systems, and polyherbal formulations in the management of rheumatoid arthritis
Gadge Antiviral and Immunity-modulating Natural Herbs in the Prevention of COVID-19
WO2003006033A3 (fr) Formulation a base de plantes medicinales
Gopal et al. Investigation of in-vitro anti-oxidant, anti-inflammatory and anti-arthritic activity of aerial parts of Securinega leucopyrus (Willd.) Muell
WO2003018535A3 (fr) Nouvelles aminobenzophenones
Bansal et al. Hepatoprotective models and various natural product used in hepatoprotective agents: a review
Mandal et al. Antiulcer agents: a pharmacological update of the past ten years
Negi et al. Natural home remedies may act as potential immunomodulators to protect against SARS-CoV-2 infection.
Kamble et al. A review on current nutraceuticals in the management of osteoarthritis
GB0416315D0 (en) Herbo-mineral formulation for refractory leukemias and lymphomas
Qayyum et al. Potential efficacy of Turmeric as an anti-inflammatory agent and antioxidant in the treatment of Osteoarthritis
Zampieron et al. Natural support for autoimmune and inflammatory disease

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 10257092

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP